Skip to content

Clinical trials

Phase 3 Polyradiculoneuropathy, Chronic Inflammatory Demyelinating trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Phase: Phase 3 Country / region: Germany Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20101
20122
20141
20151
20161
20242
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting4
Active, not recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
CSL Behring3
Sanofi3
Baxalta now part of Shire2
Dianthus Therapeutics1
Grifols Therapeutics LLC1
Novartis Pharmaceuticals1
Takeda1
argenx1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating13
Autoimmune Diseases of the Nervous System2
Nervous System Diseases2
Polyradiculoneuropathy2
Autoimmune Diseases1
Demyelinating Diseases1
Immune System Diseases1
Neuromuscular Diseases1
Peripheral Nervous System Diseases1
Polyneuropathies1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.